User profiles for Luigi Nocera
 | Luigi NoceraUniversità Vita-Salute San Raffaele, Milan, Italy Verified email at hsr.it Cited by 1393 |
Development and internal validation of a novel model to identify the candidates for extended pelvic lymph node dissection in prostate cancer
Background Preoperative assessment of the risk of lymph node invasion (LNI) is mandatory
to identify prostate cancer (PCa) patients who should receive an extended pelvic lymph …
to identify prostate cancer (PCa) patients who should receive an extended pelvic lymph …
Robot-assisted radical prostatectomy with the novel Hugo robotic system: initial experience and optimal surgical set-up at a tertiary referral robotic center
We describe the first five robot-assisted radical prostatectomies (RARPs) performed with the
new Hugo RAS system (Medtronic, Minneapolis, MN, USA) in Europe. The five patients …
new Hugo RAS system (Medtronic, Minneapolis, MN, USA) in Europe. The five patients …
Neoadjuvant pembrolizumab and radical cystectomy in patients with muscle-invasive urothelial bladder cancer: 3-year median follow-up update of PURE-01 trial
Purpose: The PURE-01 study (NCT02736266) pioneered the neoadjuvant immune-checkpoint
inhibitor (ICI) therapy before radical cystectomy (RC) in patients with muscle-invasive …
inhibitor (ICI) therapy before radical cystectomy (RC) in patients with muscle-invasive …
[HTML][HTML] Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant …
Background The most recent overall survival (OS) and adverse event (AE) data have not
been compared for the three guideline-recommended high-risk non-metastatic castration-…
been compared for the three guideline-recommended high-risk non-metastatic castration-…
Outcomes of robot-assisted radical prostatectomy with the Hugo RAS surgical system: initial experience at a high-volume robotic center
…, M Peraire, L Sarchi, A Mottaran, L Nocera… - European Urology …, 2023 - Elsevier
Clinical data on robot-assisted radical prostatectomy (RARP) performed with the new Hugo
robot-assisted surgery (RAS) system are scarce. We described surgical outcomes of 112 …
robot-assisted surgery (RAS) system are scarce. We described surgical outcomes of 112 …
Incidence and survival rates of contemporary patients with invasive upper tract urothelial carcinoma
Background Contemporary incidence and mortality rates of upper tract urothelial carcinoma
(UTUC) are unavailable. Objective To describe contemporary UTUC incidence and mortality …
(UTUC) are unavailable. Objective To describe contemporary UTUC incidence and mortality …
Clinical outcomes and adverse events after first-line treatment in metastatic renal cell carcinoma: a systematic review and network meta-analysis
Purpose: Four recent first-line clinical trials leveraging immune-oncology agents
demonstrated an overall survival (OS) benefit relative to sunitinib. We aimed to provide formal …
demonstrated an overall survival (OS) benefit relative to sunitinib. We aimed to provide formal …
Surgical safety of radical cystectomy and pelvic lymph node dissection following neoadjuvant pembrolizumab in patients with bladder cancer: prospective assessment …
No data are available on the surgical safety of radical cystectomy (RC) and pelvic lymph node
dissection (PLND) after the administration of checkpoint inhibitors. We aimed at reporting …
dissection (PLND) after the administration of checkpoint inhibitors. We aimed at reporting …
Robot-assisted sacropexy with the novel HUGO robot-assisted surgery system: initial experience and surgical setup at a tertiary referral robotic center
Introduction and Hypothesis: Robotic sacropexy (RSC) emerged in the last years as a valid
alternative to the laparoscopic technique. However, the robotic approach is still limited by …
alternative to the laparoscopic technique. However, the robotic approach is still limited by …
Overall survival after systemic treatment in high-volume versus low-volume metastatic hormone-sensitive prostate cancer: systematic review and network meta …
Context Novel prospective randomized controlled observations addressing combination
therapy in metastatic hormone-sensitive prostate cancer (mHSPC) have demonstrated …
therapy in metastatic hormone-sensitive prostate cancer (mHSPC) have demonstrated …